Divalproex Sodium
Product Images NDC 64725-0797

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 64725-0797). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 0797)

This is a description of a medication called Divalproex Sodium DR, which comes in tablet form with a potency of 250mg. The package contains 15 tablets and is coded with an NDC (National Drug Code) of 62756-797-88. The lot number is not provided, but it indicates that it was produced by Sun Pharma and repackaged by TY.A. Pharmaceuticals, located in Tallahassee, FL. The package insert should be consulted for dosing information as it is not provided.*

FDA Label Image

Label Image (64725 0798)

This is a description of a prescription drug called Divalproex Sod. DR 500MG TAB, which is available in a 100-count bottle. This drug can only be obtained with a prescription (RX ONLY) and the label contains the National Drug Code (NDC) 62756-798-88. The lot number is 00K and the expiration date is not specified (XX-XX-XX). It is manufactured by Sun Pharma and the packaging was handled by T.Y.A. Pharmaceuticals located in Tallahassee, FL. The label instructs to consult the package insert for dosage information.*

FDA Label Image

Divalproex-na-fig1 (Divalproex Na Fig1)

This text provides information about two studies where the efficacy of Divalproex sodium delayed-release tablets and Placebo was studied. The identification of the studies as "Study 1" and "Study 2" is given. The asterisk signifies statistical significance at a p-value of less than 0.05 for two different rating scales, YMRS and MRS.*

FDA Label Image

Divalproex-na-fig2 (Divalproex Na Fig2)

This text provides information on two studies involving the medication Divalproex Sodium Delayed-release Tablets, also known as DVPX. The first study involved a mean dose of 1087 mg/day, while the second study involved either a dose of 500 or 1000 mg/day. This information can be useful for medical professionals and researchers studying the use and effectiveness of Divalproex Sodium Delayed-release Tablets.*

FDA Label Image

Divalproex-na-fig3 (Divalproex Na Fig3)

FDA Label Image

Divalproex-na-fig4 (Divalproex Na Fig4)

FDA Label Image

Divalproex-na-structure (Divalproex Na Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.